GCTK
GlucoTrack Inc (GCTK)
Healthcare • NASDAQ • $0.80-6.93%
- Symbol
- GCTK
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Price
- $0.80
- Daily Change
- -6.93%
- Market Cap
- $2.93M
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $15.90
- 52W Low
- $0.62
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- 0.77
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
Company websiteResearch GCTK on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.